Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts

Nadia A. Zerhouni, Marc Maes, Charles Sultan, Stephen Rothwell, Claude J. Mlgeon

Research output: Contribution to journalArticle

Abstract

The effects of 5,10-secoestra-4,5-diene-3,10,17-trione (Compound I) and 5,10-seco-19-norpregna-4,5-diene,3,10,20-trione (Compound II) on the 5α-reductase activity and on the androgen receptors of normal human sex skin fibroblasts were investigated. The Vmax and Km, of the transformation of testosterone to 5α-reduced products was 387 pg/μg DNA/30 min and 234 × 10-9M, respectively. When the inhibitors were introduced in the assay, the 5α-reductase activity was markedly reduced, Compound I being a less potent inhibitor than Compound II. At 15 min, the inhibition was greater than at 30 and 60 min. The K1for Compound I was 160 × 10-6M with a Vmax of 83 to 553 pg/Pg DNA/30 min. For Compound II, the Ki was 0.53 × 10-6M with a Vmax of 70 to 340 pg/yg DNA/30 min. The inhibition was of the noncompetitive type. Studies with androgen receptors showed that Compound I had a lower affinity for the receptors than Compound II. The ID50 for a3H-DHT and 3H-T for Compound I were 42.9 × 10-7M and 8.6 × 10-7M, respectively, whereas for Compound II, they were 10.6 × 10-7M and 4.8 × 10-7M.

Original languageEnglish (US)
Pages (from-to)277-285
Number of pages9
JournalSteroids
Volume33
Issue number3
DOIs
StatePublished - 1979

Fingerprint

Secosteroids
Fibroblasts
Human Activities
Skin
Oxidoreductases
Androgen Receptors
DNA
Testosterone
Assays

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Cite this

Zerhouni, N. A., Maes, M., Sultan, C., Rothwell, S., & Mlgeon, C. J. (1979). Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts. Steroids, 33(3), 277-285. https://doi.org/10.1016/0039-128X(79)90004-7

Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts. / Zerhouni, Nadia A.; Maes, Marc; Sultan, Charles; Rothwell, Stephen; Mlgeon, Claude J.

In: Steroids, Vol. 33, No. 3, 1979, p. 277-285.

Research output: Contribution to journalArticle

Zerhouni, NA, Maes, M, Sultan, C, Rothwell, S & Mlgeon, CJ 1979, 'Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts', Steroids, vol. 33, no. 3, pp. 277-285. https://doi.org/10.1016/0039-128X(79)90004-7
Zerhouni, Nadia A. ; Maes, Marc ; Sultan, Charles ; Rothwell, Stephen ; Mlgeon, Claude J. / Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts. In: Steroids. 1979 ; Vol. 33, No. 3. pp. 277-285.
@article{ea1da483d78a42ef94a1b43152414d14,
title = "Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts",
abstract = "The effects of 5,10-secoestra-4,5-diene-3,10,17-trione (Compound I) and 5,10-seco-19-norpregna-4,5-diene,3,10,20-trione (Compound II) on the 5α-reductase activity and on the androgen receptors of normal human sex skin fibroblasts were investigated. The Vmax and Km, of the transformation of testosterone to 5α-reduced products was 387 pg/μg DNA/30 min and 234 × 10-9M, respectively. When the inhibitors were introduced in the assay, the 5α-reductase activity was markedly reduced, Compound I being a less potent inhibitor than Compound II. At 15 min, the inhibition was greater than at 30 and 60 min. The K1for Compound I was 160 × 10-6M with a Vmax of 83 to 553 pg/Pg DNA/30 min. For Compound II, the Ki was 0.53 × 10-6M with a Vmax of 70 to 340 pg/yg DNA/30 min. The inhibition was of the noncompetitive type. Studies with androgen receptors showed that Compound I had a lower affinity for the receptors than Compound II. The ID50 for a3H-DHT and 3H-T for Compound I were 42.9 × 10-7M and 8.6 × 10-7M, respectively, whereas for Compound II, they were 10.6 × 10-7M and 4.8 × 10-7M.",
author = "Zerhouni, {Nadia A.} and Marc Maes and Charles Sultan and Stephen Rothwell and Mlgeon, {Claude J.}",
year = "1979",
doi = "10.1016/0039-128X(79)90004-7",
language = "English (US)",
volume = "33",
pages = "277--285",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Selective inhibition by secosteroids of 5α-reductase activity in human sex skin fibroblasts

AU - Zerhouni, Nadia A.

AU - Maes, Marc

AU - Sultan, Charles

AU - Rothwell, Stephen

AU - Mlgeon, Claude J.

PY - 1979

Y1 - 1979

N2 - The effects of 5,10-secoestra-4,5-diene-3,10,17-trione (Compound I) and 5,10-seco-19-norpregna-4,5-diene,3,10,20-trione (Compound II) on the 5α-reductase activity and on the androgen receptors of normal human sex skin fibroblasts were investigated. The Vmax and Km, of the transformation of testosterone to 5α-reduced products was 387 pg/μg DNA/30 min and 234 × 10-9M, respectively. When the inhibitors were introduced in the assay, the 5α-reductase activity was markedly reduced, Compound I being a less potent inhibitor than Compound II. At 15 min, the inhibition was greater than at 30 and 60 min. The K1for Compound I was 160 × 10-6M with a Vmax of 83 to 553 pg/Pg DNA/30 min. For Compound II, the Ki was 0.53 × 10-6M with a Vmax of 70 to 340 pg/yg DNA/30 min. The inhibition was of the noncompetitive type. Studies with androgen receptors showed that Compound I had a lower affinity for the receptors than Compound II. The ID50 for a3H-DHT and 3H-T for Compound I were 42.9 × 10-7M and 8.6 × 10-7M, respectively, whereas for Compound II, they were 10.6 × 10-7M and 4.8 × 10-7M.

AB - The effects of 5,10-secoestra-4,5-diene-3,10,17-trione (Compound I) and 5,10-seco-19-norpregna-4,5-diene,3,10,20-trione (Compound II) on the 5α-reductase activity and on the androgen receptors of normal human sex skin fibroblasts were investigated. The Vmax and Km, of the transformation of testosterone to 5α-reduced products was 387 pg/μg DNA/30 min and 234 × 10-9M, respectively. When the inhibitors were introduced in the assay, the 5α-reductase activity was markedly reduced, Compound I being a less potent inhibitor than Compound II. At 15 min, the inhibition was greater than at 30 and 60 min. The K1for Compound I was 160 × 10-6M with a Vmax of 83 to 553 pg/Pg DNA/30 min. For Compound II, the Ki was 0.53 × 10-6M with a Vmax of 70 to 340 pg/yg DNA/30 min. The inhibition was of the noncompetitive type. Studies with androgen receptors showed that Compound I had a lower affinity for the receptors than Compound II. The ID50 for a3H-DHT and 3H-T for Compound I were 42.9 × 10-7M and 8.6 × 10-7M, respectively, whereas for Compound II, they were 10.6 × 10-7M and 4.8 × 10-7M.

UR - http://www.scopus.com/inward/record.url?scp=0018742170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018742170&partnerID=8YFLogxK

U2 - 10.1016/0039-128X(79)90004-7

DO - 10.1016/0039-128X(79)90004-7

M3 - Article

C2 - 442123

AN - SCOPUS:0018742170

VL - 33

SP - 277

EP - 285

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 3

ER -